Rossari Biotech
ROSSARI · Chemicals > Chemicals · Chairman: Edward Menezes · MD: Sunil Chari · Listing date: July 24, 2020 · Employees: 651 · Mumbai · http://www.rossari.com

Stock Price vs Company Growth
1d
3.3%
1w
1.6%
1m
5.6%
3m
7.9%
6m
8.0%
1y
28.6%
5y
16.2%
all
6.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 504 3.3%
458
573
Company Overview

Sales
2,550 Cr
Growth: 14.9%
Profit after Tax
151 Cr
Growth: 1.0%
Small Cap
2,792 Cr
P/E: 18.5x
Industry P/E: 27.3x
Fundamentals

Sales (Cr) ₹ 2,550
Growth 14.9%
EBITDA 11.7%
P/S 1.1x
Dividend 0.1%
P/E 18.5x
Book Value ₹ 247
PEG Ratio 1.3x
ROE 11.5%
P/B 2.1x
Shareholding Pattern

Institutions
Sbi Small Cap Fund
7.02 %
Uti Flexi Cap Fund
1.9 %
Stichting Depositary Apg Emerging Markets Equity Pool
1.66 %
Taiyo Greater India Fund Ltd
1.29 %
Goldman Sachs India Limited
1.21 %
Promoters
Edward Menezes
29.34 %
Sunil Srinivasan Chari
29.28 %
Rossari Biotech India Pvt Ltd
5.49 %
Jyotishna Sunil Chari
1.82 %
Anita Menezes
1.82 %
Others
Plutus Wealth Management Llp
1.37 %
India Acorn Fund Ltd
1.28 %
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products.
Investors (28)
Followers (11)